» Articles » PMID: 6222136

Paroxysmal Nocturnal Hemoglobinuria: Deficiency in Factor H-like Functions of the Abnormal Erythrocytes

Overview
Journal J Exp Med
Date 1983 Jun 1
PMID 6222136
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) contained a subpopulation that lacked membrane-associated Factor H-like activity present on normal human erythrocytes. Initial deposition of C3b on the erythrocytes was effected using a fluid phase C3 convertase. The cells were then treated with fluorescein-labeled C3 and the cell-bound C3 convertase. Analysis utilizing the fluorescence-activated cell sorter revealed two distinct cell populations, one of which was highly fluorescent, indicating a large number of C3b molecules per cell. Only this population (43%) was susceptible to lysis (44%) when exposed to acidified serum before C3b deposition. The less fluorescent population resembled normal human erythrocytes and was not affected by prior treatment with acidified serum. Since C3b deposition occurred almost exclusively on the complement-sensitive cells in the PNH erythrocyte population, these cells could be examined for the Factor H-like regulatory activities without prior isolation. These functions include enhancement of inactivation of erythrocyte-bound C3b by Factor I and acceleration of the decay of erythrocyte-bound C3 convertase, C3b,Bb. It was found that C3b on PNH erythrocytes was 100-fold less susceptible to inactivation by Factor I than C3b on normal human erythrocytes. The half-life at 22 degrees C of C3b,Bb on PNH erythrocytes was threefold greater than on normal human erythrocytes and similar to that of the enzyme bound to particles that do not possess Factor H-like activity. These observations suggest that the abnormal susceptibility of PNH erythrocytes to lysis by complement is due to a functional deficiency in one or more of the Factor H-like proteins present on normal human erythrocytes.

Citing Articles

Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going.

Risitano A Transl Med UniSa. 2014; 8:43-52.

PMID: 24778997 PMC: 4000462.


Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.

Pfrommer G, Dickens S, Wilson M, Young B, Kozel T Infect Immun. 1993; 61(10):4360-6.

PMID: 8406826 PMC: 281167. DOI: 10.1128/iai.61.10.4360-4366.1993.


The membrane attack complex.

MULLER-EBERHARD H Springer Semin Immunopathol. 1984; 7(2-3):93-141.

PMID: 6387983 DOI: 10.1007/BF01893017.


The chemistry and biology of complement receptors.

Schreiber R Springer Semin Immunopathol. 1984; 7(2-3):221-49.

PMID: 6238434 DOI: 10.1007/BF01893021.


The alternative pathway of complement.

Pangburn M, MULLER-EBERHARD H Springer Semin Immunopathol. 1984; 7(2-3):163-92.

PMID: 6238433 DOI: 10.1007/BF01893019.


References
1.
Hoffman E . Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata. Immunochemistry. 1969; 6(3):391-403. DOI: 10.1016/0019-2791(69)90296-1. View

2.
Hoffmann E . Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action. Immunochemistry. 1969; 6(3):405-19. DOI: 10.1016/0019-2791(69)90297-3. View

3.
Ballow M, Cochrane C . Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969; 103(5):944-52. View

4.
Gotze O, MULLER-EBERHARD H . Lysis of erythrocytes by complement in the absence of antibody. J Exp Med. 1970; 132(5):898-915. PMC: 2138874. DOI: 10.1084/jem.132.5.898. View

5.
Gotze O, MULLER-EBERHARD H . Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system. N Engl J Med. 1972; 286(4):180-4. DOI: 10.1056/NEJM197201272860403. View